A groundbreaking protocol promises significant advances for patients with bladder cancer. New therapeutic combinations show ...

Researchers are a step closer to revolutionizing how doctors use radiotherapy to treat patients with muscle-invasive bladder ...

The subtypes investigated in bladder cancer were CK19 ... has also been suggested by the presence of skip metastatic lesions to more advanced lymphatic stations and increased lymph node accruals.

The term nonmuscle invasive bladder cancer covers a spectrum of tumors with varying degrees of clinical behavior. The low-grade Ta lesions commonly recur but rarely progress to muscle invasion.

Instead of going from tumor cells to fat cells, in muscle-invasive bladder cancer, the combination therapy converted tumor ...

Pain from conditions such as endometriosis could be alleviated if the gut’s resident bacteria can be understood and tamed.

2007;4(8):432-443. Raman and colleagues reported that, following definitive surgical resection of upper-tract TCC (nephroureterectomy or segmental ureterectomy), bladder tumors developed in 44% of ...

Trodelvy is a prescription drug used to treat certain breast and bladder cancers. Learn about the drug's uses, success rate, ...

Benign adrenal tumors were associated with an increased risk for other cancers, including thyroid, lung, stomach, and bladder.

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and tolerable in patients with locally advanced or metastatic bladder cancer.

After unlocking commercial supply and enlisting a manufacturing partner earlier this year, Ferring Pharmaceuticals has ...